Axillary Adenopathy Reported After Recent COVID-19 Vaccination
Management approach to these findings includes axillary ultrasound if clinical concern persists six weeks after final dose of vaccine
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.